Chemicals company DSM has not managed to sell its Special Products unit to US investor Arseal Capital Partners, the company said in a statement on Tuesday.
The sale, announced in March last year, fell through because of European Commission demands, DSM said.
The company said it will look for a new buyer for the unit as part of its previously announced strategy to focus on life and material sciences.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation